Aggressive NK Cell Leukemia - 24 Studies Found
| Terminated |
: Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia :
|
| Terminated |
: Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia : T-Cell Large Granular Lymphocytic Leukemia : 2006-01-16 : Drug: MTX followed by fludarabine MTX should be administered with 10-20mg weekly, calculated according t |
| Completed |
: Prospective, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (Methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia : Large Granular Lymphocytes Leukemia : 2013-10-22 :
|
| Completed |
: Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia :
|
| Terminated |
: Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte Leukemia :
: |
| Terminated |
: Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL) : Leukemia : 2010-08-27 : Drug: Alemtuzumab 10 mg by vein over 2 hours on Days 1 to 10 of a 28 day cycle. |
| Completed |
: Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia : Leukemia : 2001-07-11 : Biological: monoclonal antibody Mik-beta-1 |
| Completed |
: Alemtuzumab (Campath ) to Treat T-Large Granular Lymphocyte Leukemia : Lymphoproliferative Disorders : 2006-06-27 : Drug: Alemtuzumab (Campath) |
| Completed |
: Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer :
|